GEODE CAPITAL MANAGEMENT, LLC - PHATHOM PHARMACEUTICALS INC ownership

PHATHOM PHARMACEUTICALS INC's ticker is PHAT and the CUSIP is 71722W107. A total of 85 filers reported holding PHATHOM PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.6%.

Quarter-by-quarter ownership
GEODE CAPITAL MANAGEMENT, LLC ownership history of PHATHOM PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$7,079,127
+0.9%
682,570
+39.3%
0.00%0.0%
Q2 2023$7,018,561
+119.1%
490,123
+9.3%
0.00%
Q1 2023$3,203,082
+65523.5%
448,611
+3.1%
0.00%
-100.0%
Q4 2022$4,881
-99.9%
435,044
+8.1%
0.00%0.0%
Q3 2022$4,457,000
+52.2%
402,292
+16.0%
0.00%
Q2 2022$2,928,000
-31.4%
346,936
+10.6%
0.00%
-100.0%
Q1 2022$4,271,000
-25.9%
313,817
+7.0%
0.00%0.0%
Q4 2021$5,767,000
-36.7%
293,198
+3.3%
0.00%0.0%
Q3 2021$9,112,000
-4.3%
283,863
+0.9%
0.00%0.0%
Q2 2021$9,524,000
+21.0%
281,373
+34.3%
0.00%0.0%
Q1 2021$7,869,000
+33.5%
209,508
+18.0%
0.00%0.0%
Q4 2020$5,895,000
-11.5%
177,474
-2.3%
0.00%0.0%
Q3 2020$6,659,000
+13.5%
181,599
+1.8%
0.00%0.0%
Q2 2020$5,869,000
+41.3%
178,342
+10.8%
0.00%0.0%
Q1 2020$4,155,000
-56.5%
160,927
-47.6%
0.00%0.0%
Q4 2019$9,554,000306,8680.00%
Other shareholders
PHATHOM PHARMACEUTICALS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Medicxi Ventures Management (Jersey) Ltd 3,760,869$39,000,21212.45%
Frazier Life Sciences Management, L.P. 10,109,279$104,833,2236.96%
Decheng Capital Management III (Cayman), LLC 850,000$8,814,5002.94%
Carlyle Group Inc. 3,496,808$36,191,9631.57%
Ghost Tree Capital, LLC 395,000$4,096,1501.35%
Newtyn Management, LLC 500,000$5,185,0001.28%
Altium Capital Management LP 220,000$2,281,4001.19%
StepStone Group LP 422,085$4,377,0210.98%
MPM BioImpact LLC 347,332$3,601,8330.96%
NEA Management Company, LLC 1,276,595$12,238,2900.94%
View complete list of PHATHOM PHARMACEUTICALS INC shareholders